Skip to content

To study the effectiveness of Angustura vera in the management of Knee Osteoarthritis

To study the effectiveness of Angustura vera in Knee Osteoarthritis using Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index: Single arm, interventional study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106468
Enrollment
41
Registered
2026-03-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M17- Osteoarthritis of knee

Interventions

Intervention1: Angustura vera: Angustura vera will be given to all specifically indicated cases based on the susceptibility, twice daily for 3 days. Follow up will be done at every 15 days for a perio

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Cases of primary knee osteoarthritis. 2. Patients diagnosed under ACR Diagnostic Guidelines for Osteoarthritis of knee. 3. Radiologically confirmed cases of knee Osteoarthritis (Kellgren Lawrence Grade I III). 4. Patients who have already had other method of treatment but now intend to undergo homoeopathic treatment, after providing a gap of two weeks as wash-out period. 5. Baseline WOMAC score indicating mild (25-41) to moderate symptoms (42-69).

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women. 2. Patients with Psychiatric disorders and drug addiction. 3. Presence of unstable or serious medical illnesses such as uncontrolled diabetes, thyroid disease, cardiovascular disease, hepatic or renal failure, neurological disorders that may interfere with treatment or assessment. 4. Patients who continue to be under other method of treatment. 5. Patients not willing to undergo any investigation, if so advised. 6. Patient who may discontinue their treatment. 7. Patient who are intermittently taking other method of treatment during the homoeopathic treatment.

Design outcomes

Primary

MeasureTime frame
To compare the WOMAC scores at baseline and after 4 months of intervention to assess changes in pain, stiffness, and functional limitation.Timepoint: At baseline and after 4 months of intervention

Secondary

MeasureTime frame
To evaluate the causal relationship between the intervention and clinical outcome using MONARCH criteria.Timepoint: When improvement begins till 4 months of intervention;To assess the adverse drug reactions reported during study.Timepoint: At every 15 days post-intervention till 4 months.

Countries

India

Contacts

Public ContactDr Shruti Jain Vij

National Institute of Homoeopathy

drshrutijainvij@gmail.com8527085598

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026